UK MHRA Pro-innovation Regulation of Technologies Review: Life Sciences and the government response (Catapult’s regulatory round-up May)

The Pro-innovation Regulation of Technologies review explores the overarching barriers to new technologies faced by regulators and those who interact with regulation in numerous sub-sectors within the life sciences as well as explores opportunities for changes in the regulation of specific technologies.

This report provides recommendations on:

• Common regulatory challenges that impact innovation and growth across multiple areas of life sciences,
• Regulation of medicines, advanced therapeutics and medical devices in the UK, including with regard to the Medicines & Healthcare products Regulatory Agency (MHRA) and the wider regulatory system through the National Institute for Health and Care Excellence (NICE).
• Opportunities for better regulation in the life sciences beyond human health, including novel foods, waste valorisation and cell free systems.

Published on the 2nd of June 2023. Read the entire regulatory round-up for the month of May published and curated by Catapult here.